- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 3, Pages 280
Publisher
MDPI AG
Online
2021-03-22
DOI
10.3390/ph14030280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
- (2021) Javier Martinez-Useros et al. Cancers
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
- (2020) Eric S Christenson et al. LANCET ONCOLOGY
- Repurposing drugs in oncology: From candidate selection to clinical adoption
- (2020) Pan Pantziarka et al. SEMINARS IN CANCER BIOLOGY
- Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
- (2020) Serena Veschi et al. Scientific Reports
- Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
- (2020) Michael Overman et al. Journal for ImmunoTherapy of Cancer
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy
- (2020) Garth W. Tormoen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
- (2020) Kousik Kesh et al. Microbial Cell Factories
- The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
- (2020) Won Jin Ho et al. Nature Reviews Clinical Oncology
- Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
- (2020) Wenjie Yang et al. Annals of Translational Medicine
- Repurposing old drugs to fight multidrug resistant cancers
- (2020) Jelena Dinić et al. DRUG RESISTANCE UPDATES
- Recycling the Purpose of Old Drugs to Treat Ovarian Cancer
- (2020) Mariana Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of bacterial contamination in bile on pancreatic cancer cell survival
- (2020) Hannah R. Shrader et al. SURGERY
- Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway
- (2020) Tao Li et al. ONCOLOGY REPORTS
- The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
- (2020) Sona Ciernikova et al. Biomedicines
- Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine
- (2020) Cristina P.R. Xavier et al. CANCER LETTERS
- Cancer and the dopamine D2 receptor: a pharmacological perspective
- (2019) Jillian S Weissenrieder et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma
- (2019) Anne Wynn et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
- (2019) Sepideh Aminzadeh-Gohari et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Metformin Alters the Duodenal Microbiome and Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity
- (2019) Tien S Dong et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
- (2019) Jingjing Lu et al. JOURNAL OF BIOMEDICAL OPTICS
- Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy
- (2019) Vikram Shaw et al. SEMINARS IN CANCER BIOLOGY
- Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
- (2019) Can Huang et al. Cancers
- The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
- (2019) Rosalba Florio et al. Cancers
- Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models
- (2018) Ryan M Thomas et al. CARCINOGENESIS
- Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
- (2018) Herbert Hurwitz et al. INVESTIGATIONAL NEW DRUGS
- Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling
- (2018) Wanxing Duan et al. ONCOLOGY REPORTS
- Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling
- (2018) Ke Chen et al. ONCOLOGY REPORTS
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
- (2018) Lei Huang et al. BMC Medicine
- Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1
- (2018) Fan Jiang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
- (2018) Serena Veschi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway
- (2018) Xin Wang et al. Scientific Reports
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Current and future therapies for advanced pancreatic cancer
- (2017) Rohan Gupta et al. JOURNAL OF SURGICAL ONCOLOGY
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
- (2017) Ke Chen et al. Molecular Cancer
- Drug repurposing in cancer
- (2017) Linda Sleire et al. PHARMACOLOGICAL RESEARCH
- Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer
- (2017) Alok Ranjan et al. TUMOR BIOLOGY
- Repurposing itraconazole as an anticancer agent
- (2017) Hiroshi Tsubamoto et al. Oncology Letters
- Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
- (2017) Yi-Wei Dong et al. Oncotarget
- Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy
- (2017) Emma Kipps et al. Therapeutic Advances in Medical Oncology
- The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
- (2017) Xiaogang Li et al. Scientific Reports
- High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
- (2017) Kishore Polireddy et al. Scientific Reports
- Disulfiram';s Anticancer Activity: Evidence and Mechanisms
- (2016) Yang Jiao et al. Anti-Cancer Agents in Medicinal Chemistry
- Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors
- (2016) Anthony J. O’Donoghue et al. BIOLOGICAL CHEMISTRY
- The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug
- (2016) Francesca Sacco et al. BRITISH JOURNAL OF CANCER
- Metformin and pancreatic cancer: Is there a role?
- (2016) Andre De Souza et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation
- (2016) Qian Xiao et al. CANCER RESEARCH
- Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
- (2016) Pouria Jandaghi et al. GASTROENTEROLOGY
- Pancreatic Cancer
- (2016) Cinthya S. Yabar et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study
- (2016) Xiaozhou Fan et al. GUT
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
- (2016) Faiyaz Notta et al. NATURE
- The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
- (2016) Osama Al-Assar et al. RADIOTHERAPY AND ONCOLOGY
- ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
- (2016) James M. Wilson et al. RADIOTHERAPY AND ONCOLOGY
- Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
- (2016) Alok Ranjan et al. Scientific Reports
- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
- (2015) G. Deplanque et al. ANNALS OF ONCOLOGY
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
- (2015) D. Masso-Valles et al. CANCER RESEARCH
- Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
- (2015) Amanda Kirane et al. CANCER RESEARCH
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
- (2015) A. Sebio et al. CLINICAL CANCER RESEARCH
- A rapidin vivoscreen for pancreatic ductal adenocarcinoma therapeutics
- (2015) Ozhan Ocal et al. Disease Models & Mechanisms
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
- (2015) Wenwen Chien et al. Molecular Oncology
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
- (2015) Yixiang Mao et al. Scientific Reports
- Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report
- (2015) Nicholas R Lockhart et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines
- (2015) Jonathan P. Celli et al. LASERS IN SURGERY AND MEDICINE
- Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
- (2014) M T Huggett et al. BRITISH JOURNAL OF CANCER
- Endosymbiotic theory for organelle origins
- (2014) Verena Zimorski et al. CURRENT OPINION IN MICROBIOLOGY
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
- (2014) Irene Esposito WORLD JOURNAL OF GASTROENTEROLOGY
- Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
- (2014) ITASU NINOMIYA et al. Oncology Letters
- Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
- (2014) A. Yang et al. Cancer Discovery
- Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells
- (2013) S. Kozono et al. CANCER RESEARCH
- Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
- (2013) Philippe Rougier et al. EUROPEAN JOURNAL OF CANCER
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
- (2012) A. Gonçalves et al. ANNALS OF ONCOLOGY
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
- (2012) Freddie Bray et al. LANCET ONCOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Pancreatic cancers require autophagy for tumor growth
- (2011) S. Yang et al. GENES & DEVELOPMENT
- Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer
- (2011) Eric J. Duell MOLECULAR CARCINOGENESIS
- Precursor lesions in pancreatic cancer: morphological and molecular pathology
- (2011) Christopher J. Scarlett et al. PATHOLOGY
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP inhibitors: its role in treatment of cancer
- (2011) Alice Chen Chinese Journal of Cancer
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Vitamin D for the prevention and treatment of pancreatic cancer
- (2009) Kun-Chun Chiang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- (2008) Tomislav Dragovich et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer
- (2008) Thomas B. Brunner et al. JOURNAL OF CLINICAL ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started